洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial

【ChiCTR2500108220】Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial

查看原文
立即下载
基本信息
登记号

ChiCTR2500108220

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-08-26

临床申请受理号

/

靶点

/

适应症

N/A

试验通俗题目

Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial

试验专业题目

Efficacy of a mindfulness-based intervention with and without virtual reality support to promote mental health through self-compassion and mind wandering among university students: A randomised controlled trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

The aims of the current study are to explore the effectiveness of combining mindfulness practices with VR technology in improving neuropsychological and mental health outcomes, as well as to gain better understanding of how mindfulness impact on mental wellbeing through self-compassion and mind wandering. Utilizing a two-arm RCT design, the objectives of the present study are: (1) To assess the effectiveness of mindfulness-based intervention (MBI) with VR component on neuropsychological and mental health outcomes among university students, and (2) To investigate the relationship among mindfulness, self-compassion, mind wandering, and mental health outcomes.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Predetermined block randomisation list generated by computer

盲法

None

试验项目经费来源

/

试验范围

/

目标入组人数

35

实际入组人数

/

第一例入组时间

2025-08-25

试验终止时间

2026-06-30

是否属于一致性

/

入选标准

(1) Aged 18 or above, (2) Chinese with the ability to speak Cantonese or English, (3) able to provide written informed consent.；

排除标准

(1) with epilepsy or mental disorder diagnosis and currently on active medical or psychological treatment, and (2) likely to engage in immediate risk behaviour, such as suicide and/or violence.；

研究者信息
研究负责人姓名
请登录查看
试验机构

Hong Kong Shue Yan University

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Hong Kong Shue Yan University的其他临床试验

更多

Department of Counselling & Psychology, Hong Kong Shue Yan University的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品

同适应症药物临床试验

更多